BJDX Bluejay Diagnostics, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1704287 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-12.2%
TTM EPS YoY119.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-138.1%
ROA-107.8%
ROIC (approx.)-1,839.1%
Asset turnover—
Leverage & solvency
Liabilities / assets20.6%
Debt / equity0.00x
Current ratio3.91x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.85x
Accruals ratio-16.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | — | — |
| R&D expense | $3.05M | $3.47M |
| SG&A expense | $3.91M | $3.69M |
| Operating income | -$6.95M | -$7.17M |
| Interest expense | $839 | $823,028 |
| Net income | -$6.85M | -$7.72M |
| EBITDA | -$6.88M | -$7.09M |
| EPS (basic) | -15.25 | -456.75 |
| EPS (diluted) | -15.25 | -456.75 |
| Weighted avg. shares (diluted) | 449,043 | 45,848 |
| Balance sheet | ||
| Cash & equivalents | $5.16M | $4.30M |
| Current assets | $5.46M | $4.90M |
| PP&E, net | $1.53M | $1.51M |
| Total assets | $7.12M | $6.66M |
| Current liabilities | $1.12M | $810,368 |
| Total liabilities | $1.14M | $927,924 |
| Shareholders' equity | $5.98M | $5.73M |
| Shares outstanding | 151,133 | 138,503 |
| Cash flow statement | ||
| Operating cash flow | -$6.05M | -$7.82M |
| Capital expenditure | $173,735 | $306,783 |
| Free cash flow | -$6.23M | -$8.13M |
| Investing cash flow | -$173,735 | -$306,783 |
| Financing cash flow | $7.09M | $10.22M |
| Depreciation & amortization | $74,182 | $75,618 |
| Stock-based compensation | $6 | $20,094 |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.